1994 - Fellow of the American Association for the Advancement of Science (AAAS)
David L. Thomas focuses on Immunology, Hepatitis C, Hepatitis C virus, Virology and Internal medicine. His study in Immunology is interdisciplinary in nature, drawing from both Odds ratio, Acquired immunodeficiency syndrome and Risk factor. His biological study spans a wide range of topics, including Hepatitis B, Liver biopsy, Viral hepatitis, Cirrhosis and Liver disease.
His work carried out in the field of Hepatitis C virus brings together such families of science as Viremia, Antibody, Antigen and Vaccination. In Virology, he works on issues like Human leukocyte antigen, which are connected to Allele. David L. Thomas has included themes like Gastroenterology and Hepatitis B virus in his Internal medicine study.
His primary areas of study are Hepatitis C virus, Immunology, Internal medicine, Virology and Hepatitis C. While the research belongs to areas of Hepatitis C virus, David L. Thomas spends his time largely on the problem of Liver disease, intersecting his research to questions surrounding Liver biopsy. His Immunology research incorporates themes from Acquired immunodeficiency syndrome and Genotype.
David L. Thomas interconnects Gastroenterology, Pathology and Cardiology in the investigation of issues within Internal medicine. Virus, Hepatitis B virus, Viral hepatitis, Hepatitis and Viremia are the subjects of his Virology studies. David L. Thomas combines subjects such as Coinfection, Cirrhosis and Transmission with his study of Hepatitis C.
The scientist’s investigation covers issues in Internal medicine, Hepatitis C virus, Neuroscience, Hepatitis C and Frontotemporal dementia. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Cardiology. Within the field of Virology and Immunology he studies Hepatitis C virus.
His studies deal with areas such as Multiplex and 2019-20 coronavirus outbreak as well as Immunology. His Hepatitis C research is multidisciplinary, incorporating elements of Family medicine, Medicaid, Care Continuum and Confidence interval. His Frontotemporal dementia study which covers Atrophy that intersects with Neurodegeneration.
David L. Thomas mostly deals with Internal medicine, Magnetic resonance imaging, Hepatitis C virus, Immunology and Cerebral blood flow. His Internal medicine study frequently draws parallels with other fields, such as Harm reduction. He has researched Magnetic resonance imaging in several fields, including Positron emission tomography, Blood flow, Arterial blood and Pathology.
David L. Thomas performs integrative Hepatitis C virus and Baby boomers research in his work. His primary area of study in Immunology is in the field of Serology. David L. Thomas integrates Hepatitis C and African american in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis, management, and treatment of hepatitis C: An update
Marc G. Ghany;Doris B. Strader;David L. Thomas;Leonard B. Seeff.
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola.
Diagnosis, Management, and Treatment of Hepatitis C
Doris B. Strader;Teresa Wright;Teresa Wright;David L. Thomas;Leonard B. Seeff;Leonard B. Seeff.
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi.
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany;David R. Nelson;Doris B. Strader;David L. Thomas.
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
Jörg Ederle;Joanna Dobson;Joanna Dobson;Roland L. Featherstone;Leo H. Bonati;Leo H. Bonati.
The Lancet (2010)
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
David L. Thomas;Jacquie Astemborski;Rudra M. Rai;Frank A. Anania.
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Salim I. Khakoo;Chloe L. Thio;Maureen P. Martin;Collin R. Brooks.
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Chloe L Thio;Eric C Seaberg;Richard Skolasky;John Phair.
The Lancet (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: